LUYE pharma Joins US Firm to Develop Immuno-oncology Treatments

Drug Discovery |  News | 0 Comment | 29 May, 2018

LUYE PHARMA announced that the Group entered into a collaboration and license agreement with Elpis Biopharm, a Boston-re...Read more

FDA approves BioMarin’s metabolic disorder treatment

Drug Discovery |  News | 0 Comment | 25 May, 2018

Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...Read more

Eisai, Merck provide Update on sNDA for Lenvatinib

Drug Discovery |  News | 0 Comment | 25 May, 2018

Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...Read more

Celgene, Evotec team up on cancer treatments

Drug Discovery |  News | 0 Comment | 22 May, 2018

Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...Read more

AstraZeneca submits sNDA for Forxiga in Japan

Drug Discovery |  News | 0 Comment | 22 May, 2018

Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...Read more

Minerva’s drug shows treatment effect in schizophrenia patients

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on the development of therapi...Read more

Cabometyx gets approval in Europe for first-line kidney cancer

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- The European Commission (EC) has approved commercialization partner Ipsen's marketing application for C...Read more

Regeneron, Sanofi's drug shows positive effect in lung cancer study

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- Regeneron Pharmaceuticals and development partner Sanofi announce positive preliminary data from a...Read more

Dicerna’s hyperoxaluria treatment gets orphan status from FDA

Drug Discovery |  News | 0 Comment | 18 May, 2018

 Singapore- Dicerna Pharmaceutical’s drug recently received an orphan drug status designation for i...Read more

FDA approves first non-opioid treatment for opioid withdrawal

Drug Discovery |  News | 0 Comment | 17 May, 2018

Singapore- The U.S. Food and Drug Administration approved privately held US WorldMeds LLC's Lucemyra (lofexidine hydroch...Read more

Daré to merge with Pear Tree Pharma

Drug Discovery |  News | 0 Comment | 08 May, 2018

Singapore– Daré Bioscience, a clinical-stage women’s biopharmaceutical company has agreed t...Read more

Kindred Biosciences Receives FDA Approval of Mirataz

Drug Discovery |  News | 0 Comment | 07 May, 2018

Kindred Biosciences, Inc. a biopharmaceutical company focused on saving and improving the lives of pets, announced that ...Read more

Zai Lab in-licenses Entasis’s broad-spectrum antibiotic in APAC

Drug Discovery |  News | 0 Comment | 26 Apr, 2018

Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...Read more

Pfizer vaccine receives FDA's breakthrough therapy designation

Drug Discovery |  News | 0 Comment | 25 Apr, 2018

Pfizer recently announced that its lead Meningococcal Group B Vaccine TRUMENBA received Breakthrough Therapy designation...Read more

Zymeworks, Celgene expand bispecific antibody partnership

Drug Discovery |  News | 0 Comment | 24 Apr, 2018

Singapore - Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, announced tha...Read more

UCB to acquire Proximagen’s midazolam nasal spray

Drug Discovery |  News | 0 Comment | 20 Apr, 2018

Singapore- Belgium based UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray (US...Read more

J&J ramps up pricing for Imbruvica

Drug Discovery |  News | 0 Comment | 19 Apr, 2018

Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) con...Read more

OBI Pharma gets FDA clearance for new drug application

Drug Discovery |  News | 0 Comment | 19 Apr, 2018

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has cleared an i...Read more